Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 62.30%
March 31, 2026 61.20%
December 31, 2025 59.21%
September 30, 2025 57.91%
June 30, 2025 63.75%
March 31, 2025 63.77%
December 31, 2024 63.55%
September 30, 2024 63.93%
June 30, 2024 64.90%
March 31, 2024 65.37%
December 31, 2023 64.93%
September 30, 2023 62.50%
June 30, 2023 64.86%
March 31, 2023 69.53%
December 31, 2022 63.52%
September 30, 2022 61.61%
June 30, 2022 61.70%
March 31, 2022 61.79%
December 31, 2021 37.33%
September 30, 2021 41.80%
June 30, 2021 45.60%
March 31, 2021 44.35%
December 31, 2020 43.47%
September 30, 2020 40.95%
June 30, 2020 39.16%
Date Value
March 31, 2020 49.92%
December 31, 2019 49.88%
September 30, 2019 48.49%
June 30, 2019 52.01%
March 31, 2019 50.96%
December 31, 2018 50.82%
September 30, 2018 50.49%
June 30, 2018 51.24%
March 31, 2018 51.20%
December 31, 2017 46.65%
September 30, 2017 48.19%
June 30, 2017 51.72%
March 31, 2017 48.87%
December 31, 2016 46.60%
September 30, 2016 46.10%
June 30, 2016 45.85%
March 31, 2016 44.07%
December 31, 2015 46.88%
September 30, 2015 45.47%
June 30, 2015 44.56%
March 31, 2015 47.80%
December 31, 2014 42.56%
September 30, 2014 41.80%
June 30, 2014 41.08%
March 31, 2014 40.99%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Biomerica, Inc. -8.11%
Univec, Inc. 9.05%
Indivior Pharmaceuticals, Inc. 85.42%
Zomedica Corp. 63.51%
Bristol Myers Squibb Co. 67.95%

Gross Profit Margin (Quarterly) Related Metrics